Injection sclerotherapy.
作者信息
Worthington-Kirsch Robert L
机构信息
Clinical Assistant Professor of Radiology, Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania; and Chief, Division of Interventional Radiology, Tenet-Roxborough Memorial Hospital, Philadelphia, Pennsylvania.
出版信息
Semin Intervent Radiol. 2005 Sep;22(3):209-17. doi: 10.1055/s-2005-921954.
Abstract
Injection sclerotherapy is an important primary and adjunctive therapy in the spectrum of care for superficial venous insufficiency. This article briefly reviews the history of the procedure, agents used, technique, and outcomes. The place of injection sclerotherapy in the treatment of superficial venous disease is discussed.
摘要
相似文献
1
Injection sclerotherapy.
Semin Intervent Radiol. 2005 Sep;22(3):209-17. doi: 10.1055/s-2005-921954.
2
Endovenous laser ablation and sclerotherapy for treatment of varicose veins.
Semin Cutan Med Surg. 2008 Dec;27(4):264-75. doi: 10.1016/j.sder.2008.08.001.
3
The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
J Vasc Surg. 2011 May;53(5 Suppl):2S-48S. doi: 10.1016/j.jvs.2011.01.079.
4
Standard guidelines for care: sclerotherapy in dermatology.
Indian J Dermatol Venereol Leprol. 2011 Mar-Apr;77(2):222-31. doi: 10.4103/0378-6323.77478.
5
Endovenous laser ablation and foam sclerotherapy for varicose veins: does the presence of perforating vein insufficiency affect the treatment outcome?
Acta Radiol. 2011 Apr 1;52(3):278-84. doi: 10.1258/ar.2010.100356. Epub 2011 Mar 3.
6
Sclerotherapy treatment of telangiectasias and varicose veins.
Tech Vasc Interv Radiol. 2003 Sep;6(3):116-20. doi: 10.1053/s1089-2516(03)00044-1.
7
Randomised clinical trial, observational study and assessment of cost-effectiveness of the treatment of varicose veins (REACTIV trial).
Health Technol Assess. 2006 Apr;10(13):1-196, iii-iv. doi: 10.3310/hta10130.
8
Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
Eur J Vasc Endovasc Surg. 2009 Mar;37(3):343-8. doi: 10.1016/j.ejvs.2008.08.021. Epub 2008 Oct 14.
9
Combination therapy of hyaluronic acid mesotherapic injections and sclerotherapy for treatment of lower leg telangiectasia without major venous insufficiency: a preliminary clinical study.
Clin Appl Thromb Hemost. 2014 Apr;20(3):326-30. doi: 10.1177/1076029612461844. Epub 2012 Oct 17.
10
Injection sclerotherapy for varicose veins.
Cochrane Database Syst Rev. 2002(1):CD001732. doi: 10.1002/14651858.CD001732.
引用本文的文献
1
A comparative study between cryo-laser cryo-sclerotherapy and sclerotherapy in the treatment of telangiectasia and reticular veins: A randomized controlled trial.
J Vasc Surg Venous Lymphat Disord. 2024 Jul;12(4):101874. doi: 10.1016/j.jvsv.2024.101874. Epub 2024 Mar 24.
2
Embolic Agents: Sclerotherapy.
Semin Intervent Radiol. 2024 Mar 14;41(1):79-83. doi: 10.1055/s-0043-1778656. eCollection 2024 Feb.
3
Effectiveness of Sclerotherapy to Cure Lower Limb Chronic Venous Insufficiency Grades 1-6: A Systematic Review and Meta-Analysis.
Cureus. 2023 Dec 1;15(12):e49770. doi: 10.7759/cureus.49770. eCollection 2023 Dec.
4
Usefulness of a Low-Dose Sclerosing Agent for the Treatment of Vascular Lesions in the Tongue.
Cureus. 2023 Sep 15;15(9):e45323. doi: 10.7759/cureus.45323. eCollection 2023 Sep.
5
Insights into pelvic venous disorders.
Front Cardiovasc Med. 2023 Jan 19;10:1102063. doi: 10.3389/fcvm.2023.1102063. eCollection 2023.
6
Treatment for telangiectasias and reticular veins.
Cochrane Database Syst Rev. 2021 Oct 12;10(10):CD012723. doi: 10.1002/14651858.CD012723.pub2.
7
Classifying Hydroceles of the Pelvis and Groin: An Overview of Etiology, Secondary Complications, Evaluation, and Management.
Curr Urol. 2017 Apr;10(1):1-14. doi: 10.1159/000447145. Epub 2017 Mar 30.
8
Phenol as a novel sclerosing agent: A safety and efficacy study on experimental animals.
Saudi Pharm J. 2014 Jan;22(1):71-8. doi: 10.1016/j.jsps.2013.01.007. Epub 2013 Feb 10.
本文引用的文献
1
Sclerosing foam in the treatment of varicose veins and telangiectases: history and analysis of safety and complications.
Dermatol Surg. 2002 Jan;28(1):11-5. doi: 10.1046/j.1524-4725.2002.01182.x.
2
Sclerosants in microfoam. A new approach in angiology.
Int Angiol. 2001 Dec;20(4):322-9.
3
Extensive tissue necrosis following high-concentration sclerotherapy for varicose veins.
Dermatol Surg. 2000 Jun;26(6):535-41; discussion 541-2. doi: 10.1046/j.1524-4725.2000.00033.x.
4
Sclerotherapy for venous flare.
Br J Plast Surg. 1985 Apr;38(2):241-2. doi: 10.1016/0007-1226(85)90057-8.
5
Postsclerotherapy hyperpigmentation: a histologic evaluation.
J Dermatol Surg Oncol. 1987 May;13(5):547-50. doi: 10.1111/j.1524-4725.1987.tb00940.x.
6
Small vessel sclerotherapy: an overview.
Adv Dermatol. 1988;3:221-42.
7
Determination of incidence and risk factors for postsclerotherapy telangiectatic matting of the lower extremity: a retrospective analysis.
J Dermatol Surg Oncol. 1990 Apr;16(4):327-30. doi: 10.1111/j.1524-4725.1990.tb00043.x.
8
Therapy for essential cutaneous telangiectasia.
Postgrad Med. 1977 Jan;61(1):91-5. doi: 10.1080/00325481.1977.11714509.
Zotero 插件